Table Of Content

| of Surgical Oncology 2006;93:709-712 Author Index to Volume 93 Adelelateef, A., 228 Boynukalin, Kubra, 37 \retxabala, Xabier, 615, 624, 699 Agarwal, J. P., 56 Brehant, Olivier, | Baere, Thierry, 8 Agarwal, Manish, 429 Brenner, Baruch, 529 Pas, Tommaso, 456 Aguiar, Samuel Jr., 206 Brummell, Zoe, 258 Sio, M., 181 Ahmad, Syed A., 279 Buchler, Markus W., 2 Vita, Ferdinando, 241 Aihara, Ryuusuke, 49] Bufalari, Andrea, 173 Vries, Mattijs, 564 Akamine, Shinji, 323 Bui, Luke, 439 el Rio, Paolo, 446 Akita, Hirofumi, 401 Burattini, Maria Frederic sai, Saral S., 429 Aldrighetti, Luca, 186 Bussotti, Claudia, 17 leshpande, M. S., 56, 593 Altuntas Selman, 286 Lorenzo, G., 181 Amodeo Corrado, 199 Cabanas, Jacobo, 16] on, Mary F., 559 Andreoni, Bruno, 394, 456 Caglia, Pietro, 199 shaw, K. A., 56 Aoki, Junken, 30 Cascini, G. L., 18] | Yuichiro, 401, 422, 477 Arai, Hiroyuki, 30 Castagnoli, A., 194 orsam, Ulrich J., 24 Araya, Juan C., 615 Castellano, Paolo, 241 ting, Edwina H., 564 Arnaud, Jean-Pierre, Catena, Marco, 186 nik, Zeev, 529 Arru, Marcella, 186 Cenciarelli, Sabine, 394 ogula, Cynthia, 550 \sao, Takayuki, 491 Chang, Jung Hyun, 33 Y gael, 529 Autorino, R., 18i Chang, Shyue-Yih, 468 four, Fanny, 8 Aydin, Mustafa Asim, 286 Chaturvedi, Pankaj, 56 ewirski, Wirginiusz, 304 Ayhan, Ali, 373 Chaube, Amita, 665 Chaukar, D. A., 56, 36: ishi, Mitsuharu, | 20 Bacchella, Telesforo, 338 Chen, Jian, 534 Stephen B., 129 Bachega, Wilson, 206 Chen, Wen-Chung, 294 uchi, Hidetoshi, 511 Baik, Seung-Hyuk, 145 Cheng, Shao-Bin, 27 Harroudi, Tijani, 8 Bakshi, Ashish V., 434 Chiappa, Antonio, 394 kkad, ! Barnard, Graham F., 44 Cho, Chang-Whan, 145 Dominique, 8 Basili, G., 194 Cho, Nam Hoon, 330 tabbakh, Gamal H., 379 Basso, Stefano, 199 Choi, Chan, 233 ans, Sheila, 550 Beatty, Barbara, 379 Choi, Eun Chang, 330 Bembenek, Andreas, 109 Choi, Yoo Duk, 233 Eyal, 529 Benizri, Emmanuel, 8 Chou, Shin-Cheng, 294 Gianfranco, 186 Berrios, Marcela, 699 Chu, Kin Wah, 523 rraraccio, Francesca, 241 Bertain, Emilio, 456 Chu, Pen- Yuan, 468 rreira, Fabio O., 206 Berwick, Marianne, 107 Ciardiello, Fortunato, 24 rron-Orihuela, Jose Antonio, 650 Beskow, Laura M., 100 Cooper, Kumarasen, amingo, Pietro, 199 Bex, A., 20 Cordova, Andres, 699 er, Arie, 529 Bhagwat, Roshni, 434 Crooks, D., 92 sueira, Estela R. R., 338 Biagini, Blanche, 42 Crotti, Cristiano, 456 1azzi, Renato, 186 Biffi, Roberto, 394, 456 ch, M., 92 Biliotti, G. C., 194 D’ Amico, Davide France Richard, 550 Biswas, Ghanashyam, 434 D’Cruz, Anil K., 56, 36: shner, N. E., 92 > Block, Mark I., 519 Dakin, Gregory F., 368 ury, Thomas, 550 Bold, Richard J., 167 Damiano, R., 181 ynseca, Francisco P., 206 Bonadeo, Fernando, 151 Damron, Timothy A., ter, Jason M., 129 Borghetti, Angelo F., 446 Date, Amit S., 593 ohlich, Boris E., 24 709 710 Author Index Fujii, Hisatake, 120 Imaoka, Shingi, 401, 422, 511 Kucukali, Turkan, 373 Fujimoto, Daisuke, 139 Imperatore, Vincenzo, 241 Kumar, J. Ram, 610 Fujiwara, Yoshiyuki, 477 Ina, Shinomi, 485 Kumar, Sandeep, 601633 Fukumitsu, Takamasa, 47 Inabnet, William B., 368 Kumar, Shailendra, 633 Inoue, Masao, 323 Kumar, Surender, 633 Gage, Irene, 550 Ishibashi, Nobuya, 47 Kume, Haruki, 318 Gagliano, Massimiliano, 199 Ishihara, Ryu, 422 Kumierek, Jacek, 355 Galizia, Gennaro, 241 Ishii, Hideshi, 44 Kuo, Kuang-Tai, 468 Gallardo, Jorge, 699 Ishikawa, Makoto, 30 Kusuzaki, Katsuyuki, 212 Gallo, A., 181 Ishikawa, Osamu, 401, 422, 511 Kutup, Asad, 541 Gallo, L., 181 Izbicki, Jakob R., 541 Kuwano, Hiroyuki, 491 Gao, Shunliang, 534 Ghosh, Bimal C., 42 Jager, Piet L., 564 La Manna, Giovanni, 241 Giustozzi, Giammario, 173 Jambhekar, Nirmala, 429 La Mura, Anna, 241 Goi, Takanori, 139 Jeziorski, Arkadiusz, 355 Lafon, Cyril, 268 Gomez-Rio, Manuel, 650 Jin, Denan, 36 Lardelli-Claret, Pablo, 650 Gorthi, Ganesh, 258 Joffé, Elisa Bal de Kier, 151 Last, L. D., 92 Gouma, Dirk J., 571 Johnston, Elizabeth A., 7 Lastiri, José, 151 Grana, G., 585 Johnstone, David W.., Lastoria, F., 181 Greco, E., 92 Law, C. HL. 92 Griffiths, Ewen A., 258 Kaemmerlen, Pierre, 268 Law, Wai Lun, 523 Grzesiakowska, Urszula, 304 Kaifi, Jussuf T., 541 Lazzaro, Gianluca, 456 Guimaraes, Gustavo C., 206 Kamiyama, Yoichi, 491 Lee, Jae Hyuk, 233 Guleria, Sandeep, 690 Kannan, R. Ravi, 133 Lee, Ji Shin, 233 Guven, Suleyman, 373 Kapoor, V. K., 607 Lee, Jin Seok, 330 Karag6z, Arif, 286 Lee, Kang- Young, 145 Hama, Kotaro, 30 Karakousis, Constantine P., 78, 87 Lee, Kyong Sik, 2 21 504 Hammouda, H., 228 Kart, Cavit, 373 Lee, Min Cheol, 2: 33 Harada, Ken-ichi, 120 Katayama, Kanji, 139 Lee, Min Jin, 13 Hashizume, Satoshi, 323 Katori, Hideaki, 80 Lee, Min Ro, 13 Hayashi, Tomayoshi, 323 Katz, Angela, 550 Leon, Jorge, 699 Hellmich, Gunter, 350 Kawai, Manabu, 485 Leong, A. F. P. K., 498 Hemandas, A. K., 498 Khadwal, Alka, 434 Leow, C. K., 498 Heo, Min-Kyu, 504 Kienle, Peter, 24 Lermite, Emilie, | Hepp, Juan, 699 Kim, Gwi Eon, 504 Li, Chien-Feng, 294 Herman, Paulo, 338 Kim, Hyung Seok, 233 Liefers, Gerrit-Jan, 18 Hershko, Dan D., 279 Kim, Jeong Hong, 330 Liem, Mike S. L., 18 Hill, Arnold D. K., 559 Kim, Joo-Hang, 504 Lieto, Eva, 241 a Hirao, Takafumi, 401 Kim, Ki-Suk, 504 Lim, Megan S., 25 A Hirono, Seiko, 485 Kim, Kyubo, 330 Lim, Seok-Byung, 13 Hirono, Yasuo, 139 Kim, Nam-Kyu, 145 Lin, Ching-Nan, 294 Hirose, Kazuo, 139 Kim, Se-Heon, 330 Link, Bjoern C., 541 Hoekstra, Harald J., 564 Kim, Seung II, 221, 504 Lippert, Hans, 682 Hollenberg, E., 92 Kim, Woo Ho, 13 Liu, Tse-Jia, 273 Hong, Chang Won, Kitayama, Joji, 30 Llamas-Elvira, José Manuel, 650 Horenblas, S., 20 Kitramura, Tadaichi, 318 Lo Faso, Felice, 394 Hsiung, Ching- Yeh, 294 Kleespies, Axel, 435 Lopes, Ademar, 206 Hsu, Wen-Hu, 468 Kloek, Jaap J., 571 Lopez, Marvin J., 171 Hu, Jian, 62 Knaebel, Hanns-Peter, 24 Lorimier, Gérard, | Huang, Hsuan- Ying, 294 Kondo, Keisaku, 36 Loven, David, 529 Hurd, Thelma C., 129 Kondoh, Osamu, 312 Lowy, Andrew M., 279 Koo, Bon Seok, 330 Luca, Fabrizio, 394, 456 Ibacache, Gilda, 624 Koyama, Isamu, 68, 72 Lucaroni, Elena, 173 Idelevich, Efraim, 529 Krawczyk, Marek, 304 Ludwig, Klaus, 350 Author Index Luo, Huiying, 578 Munoz, Sergio, 624 Pandey, Durgatosh, 133 Lyckholm, Laurie, 521 Muramatsu, Michiko, ‘andey, Manoj, 640 Muraoka, Masashi, 32 itvaidya, G. H., at Machado, Marcel Autran C. rikh, Purvish M., Machado, Marcel C. C., 338 Nagahara, Hisashi, 44 Byeong Wox , 4 504 Mack, Lloyd A., 345 Nagawa, Hirokazu, 30 Park, Chang Soo, 233 . Madia, Carmelo, 199 Nagayasu, Takeshi, rk, Jae-Gahb,| 3S Magnant, Colette, 550 Nakagawa, Wilson T., ark, Kyu Joo, 13 Mahajan, Vikash, 133 Nakaizumi, Akihiko, 5 k, Yoon-Ah, 145 Maier, B. A., 92 Nam, Jong Hee, 233 <, Kumar Alok, 56, 593 Makdissi, Fabio F., 338 Namm, Jukes P.. 76 aul, M. A., 410 Maluenda, Fernando, 699 Narayanan, Prasad, 434 rdona, S., 181 Manganas, Dimitri, 8 Nasierowska-Guttmeje! eri, A., 194 Mann, Oliver, 541 Nasir, Serdar, 286 essaux, Patrick, | Maricar, S. H., 498 Nejc, Dariusz, 355 tersen, Sven, 35( Markwardt, Jorn, 109 Nestler, Gerd, 682 etrucci, Peter E. Marra, L., 181 Niemierko, Andrzej, 5 iekarski, Janusz, 35: Martin, Jocelyne, 437 Nieweg, Omgo E., 18 Pinto, Margherita, Martin, Robert C. G. Nishimatsu, Hiroaki lukker, John Th. Martini, F., 194 Nishiyama, Kinji, 422 i, Piotr, 355 Matono, Keiko, 47 Noguchi, Masakuni, | , ~- Alfons. 368 5 Matsubara, Takao, 21 Nowecki, Zbigniew, 304 . Gerhard, 350 2] 5 Matsumine, Akihiko, Nozawa, Akinori, 80 Wend) J.. 564 Matsumoto, Keitaro, 323 Nudelman, Israel, 529 I zi, Simonetta, 394 Mauro, Laura V., 151 Nwogu, Chumy, 257 aicteande Susan A., 258 McDermott, Enda W., 559 Nyckowski, Pawel, 304 Ajai, 429 McMasters, Kelly M., 387 ricelli, Lydia Inés, 151 Medina-Benitez, Antonio, 650 O'Doherty, Ann, 559 Meeus, Pierre, 268 O'Higgins, Niall, 559 f . Cecily M., 559 Menegon, Paola, 8 Ogata, Yutaka, 47 uintana, Guillermo Ojea, 151 Merchant, Nikhil, 429 Ogawa, Nobuji, 68 eshi, Sajid S., 362, 420 Miller, D., 92 Ohigashi, Hiroaki, 40! Mimori, Koshi, 44 Ohno, Tetsuro, 491 Arundhati, 610, 7 Min, Kyung Whan, 233 Ohue, Masayuki, 51 | Ramadas, Go H., 279 Misra, Mahesh Chandra, 690 Oka, Tadayuki, 323 Ramia-Angel, Jose Manuel, 650 Mistry, Rajesh C., 420 Okada, Katsuya, 68, Ramos-Font, Carlos, 650 Mithieux, Francois, 268 Okamoto, Yukiko, 36 -eeson, Diana, =~ Miyashiro, Isao, 401, 422, 5 Okamura, Atsushi, 2! . Mark E., Miyata, Hiroshi, 401, 477 Okudan, Berna, 286 npel, Es ddy, 439 Miyazaki, Mizuo, 36 Okuyama, Noritaka, 2 eymond, Marc-Andre, 682 Miyazaki, Shinichi, 212 Ollila, David W., 100 ezaishiraz, Hamed, 129 Miyazawa, Mitsuo, 68, 72 Olszewski, Jerzy, 355 ci, Enrica, 173 Mizobe, Tomoaki, 47 Oosterling, S. J., 410 oire, Michel, 268 Mochiki, Erito, 491 Orditura, Michele, 24 Ivan, 615, 624, 699 Mohapatra, Sadhu C., 610, 7 Osaka, Shunzo, 312 Juan, 615, 624, 699 Monden, Morito, 477 Ota, Nobutaka, 318 b, Bruce W., 279 Moore, Harvey G., 42 Ozbek, Meltem, 286 Roca, Fernanda, 151 Moraitis, Dimitrios, 417 riguez-Fernandez, Antonio, Morandi, Ana, 151 P’eng, Fang-Ku, 273 650 Mori, Masaki, 44 Pace, Ugo, 456 mani, Antonello A., 446 Morinaga, Masafumi, 323 Pai, P. S., 56 Rossi, Benedito M., 206 Mount, Sharon L., 379 Pai, Prathamesh S., 59 sowland, Randall G., 172 Mucke, Jérg, 109 Palesty, J. Alexander, Rubio, Isabel T., 517 Miiller, Jorg, 682 Pallotta, Maria Guada! i, Wlodzimierz, 304 712 Author Index Rutkowski, Piotr, 304 Stilo, Francesco, 347 Verwaal, V. J., 20 Ryu, Junnosuke, 312 Stitzenberg, Karyn B., 100 Vezzosi, V., 194 Sudo, Tomoya, 44 Villar-Del Moral, Jesus, 650 Saetta, Angelica A., 644 Sugarbaker, Paul H., 161 Visser, Mechteld R. M., 571 Sagynaliev, Emil, 682 Sugita, Yurika, 477 von Mildenstein, Katharina, 350 Salky, Barry, 368 Sulkes, Aaron, 529 Vonk, A. M. A., 410 Salto-Tellez, M., 498 Sun, Li, 62 Sarkis, Alvaro S., 206 Sussman, Jeffrey J., 279 Wang, Aigin, 578 Sasaki, Yo, 401, 422, 511 Suurmeijer, Albert J. H., 564 Wang, Hao-Wei, 468 Sasatomi, Teruo, 47 Wang, Liang-Siun, 468 > Schlag, Peter M., 109 Tagawa, Tsutomu, 32: 5 Wang, Wenji, 578 Schulze, Tobias, 109 Takachi, Ko, 401, 422 Warner, Richard R. P., 368 Schurr, Paulus G., 541 Takahashi, Satoru, 318 Watroba, Nancy, 129 Sciannameo, Francesco, 173 Takai, Shinji, 36 Weigel, Ronald J., 343 Scoggins, Charles R., 387 Takeuchi, Takumi, 318 Welch, lan Mcl Seghi, P., 194 Takiguchi, Shuji, 477 Wen, Mei-Chin, 273 Seiler, Christoph M., 24 Talole, Sanjay D., 362 Wolfram, Lars, 541 Seong, Jinsil, 145 Tang, Ping-zhang, 464 Wright, F. C., 92 Servili, Stefano, 173 Tani, Masaji, 485 Wrzesie, Malgorzata, 355 Shaffer, Margaret, 550 Tanigawa, Nobuhiko, 36 Wu, Cheng-Chung, 273 Shah, Bhavin C., 593 Teramoto, Shinji, 318 Wu, Yulian, 534 Shaha, Ashok R., 417 Terasawa, Hiroshi, 485 Shalaby, M., 228 Testori, Alessandro, 456 Xu, Zhen-gang, 464 Shani, Adi, 529 Tewari, Mallika, 601, 610, 629, 665, Sharir, S., 92 705 Yamada, Terumasa, 51 | Shen, Hongwei, 534 Thomas, Nancy E., 100 Yamaguchi, Akio, 139 Shinozuka, Nozomi, 68 Tomimaru, Yoshito, 422, 511 Yamashita, Hiroharu, 30 Shintani, Ken, 212 Tomita, Kyoichi, 318 Yamashita, Keishi, 44 Shirouzu, Kazuo, 47 Tomshimitsu, Yasuko, 72 Yamashita, Natsumi, 4 / Shu, Kuo-Hsiung, 273 Tongaonkar, Hemant B., 420 Yamaue, Hiroki, 485 - Shukla, Hari S., 597, 604, 610, 665. Torigoe, Shojiro, 47 Yamayoshi, Takatomo, 3 23 705 Torii, Takahiro, 68, 72 Yanagawa, Takashi, 47 Shukla, Parul J., 420 Toshimitsu, Yasuko, 68 Yang, Chia-Hsin, 468 Sianesi, Mario, 446 Tozzi, F., 194 Yang, Woo-Ick, 504 Sikora, Sadiq S., 670 Tsai, Kun-Bow, 294 Yano, Masahiko, 401, 422, 477, 511 Simmons-Arnold, Linda, 379 Tsukuda, Mamoru, 80 Yasuda, Takushi, 477 Simunovic, Marko, 439 Tsuneyama, Koichi, 120 Yeh, Dah-Cherng, 273 Singh, Rajneesh K., 670 Tuech, Jean-Jacques, | Yekebas, Emre F., 541 Singh, Usha, 665 Yen, Cheng-Fang, 294 Sinha, Rohan, 610 Uchida, Atsumasa, 212 Yerushalmi, Rinat, 529 Smeenk, R. M., 20 Uchiyama, Kazuhisa, 485 Yokoyama, Koichi, 120 Smith, A. J., 92 Uehara, Hiroyuki, 51 | Yoon, Sang Nam, 13 Smith, Frederick P., 5° Yoshida, Yukihiro, 312 Sohn, Seung-Kook, Vaccaro, Carlos, 151 Yoshioka, Setsuko, 477 Soldano, Debbie A., 2 Valastro, Maurizio, 199 Yu, Junxiu, 534 Soliani, Paolo, 446 van der Elst, A., 410 Sparidans, R. W., 410 van der Sijp, J. R. M., 410 Zbar, Andrew P., 456 Specterman, Sergio, 151 van der Velden, Jacobus, 571 Zequi, Stenio C., 206 Sprangers, Mirjam A. G., 571 van Lanschot, J. Jan B., 571 Zhang, Bin, 464 Steinert, Ralf, 682 van Rijk, Maartje C., 165 Zhang, Chong, 62 Stella, Mattia, 268 Veroux, Massimiliano, 199 Zhou, Xielai, 62 Stemmer, Salomon M., 529 Veroux, Pierfrancesco, 199 Zoetmulder, F. A. N., 20 of Surgical Oncology 2006;93:713-—715 Subject Index to Volume 93 5’-deoxy-fluorouridine (5'-DFUR), cervical lymphadenecton trogen receptor-B, 504 47 cervix neoplasm, 233 mestane, 585 chemoradiotherapy, 699 tended right hepatectomy, 72 abdominal neoplasms/etiology, 682 chemoresistance, 379 abdominal retractor, 420 chemotherapy, 456 /DG-PET, 650 adamantinoma, 429 cholangiocarcinema, | 9! ula, 429 adenoma, 615 cholecystectomy, 607 » multiple linear regression adjuvant treatment, 350 cholelithiaisis, 607, 624 nodels, 47 advanced gallbladder cancer, 670 chymase, 36 anastrozole, 585 cisplatin, 323, 401 bladder, 615, 624, 640 anatomy, 338 clinical results, 212 bladder cancer, 610, 624, 629, angiogenesis, 36, colon cancer, 439, 446 633, 650, 690, 699, 705 apoptosis, 379 colorectal cancer, 13, | ) bladder disease, 610 asymptomatic, 629 combined treatment, 304 iIbladder neoplasms, 607 axillary, 129 complications, 20 bladder polyp, 690 axillary dissection, 109, 550 concomitant diseases, 18 stones, 629 continuous-infusion 5-FI trectomy, 368, 393 biochemical modulation, 47 contralateral drainage tric cancer, 30, biopsy, 559 cryosurgical ablation, 268 534 bisegmentectomy 7-8, 338 cryotherapy, 268 tric carcinoid, 368 bladder recurrence, 318 curative resection, 199 trin, 368 BMI, 705 cyclins, 241 trointestinal stromal tumor, 304 bone substitute, 212 BC (gallbladder carcinoma), 665 breast, 129 demography, 610 nib, 44 breast cancer, 109, 120, 221, 504, diagnosis, 571 citabine, 699 550 diagnostic laparoscopy sonian, 338 breast neoplasms, 165, 559 dihydropyrimidine del dissection, 133 Brooke ileostomy, 161 (DPD), 47 SD (gallstone disease), 665 double diversion, 206 CA 125, 665 double-barreled wet co 1, 564 cadmium, 640 dThdPase/DPD ratio, 4 and neck, 100 calcium phosphate cement (CPC), metals, 640 212 early diagnosis, 279 cobacter, 633 cancer, 129, 571, 615 E-cadherin, 151 atectomy, 8, 199 cancer registry, 100 ECL cell, 368 tic artery infusion, 387 capecitabine, 47, 529 elderly, 173, 186 patic artery infusion carbon dioxide/pharmacology, 682 en-bloc-esophagectom) emotherapy, 387 carcinogenesis, 504, 640 endrometrial cancer, 3 tocellular carcinoma, 68, 273 carcinoma, 559 enteric fever-Salmonella itopancreatoduodenectomy, 670 carcinoma of the penis, 133 epidermal growth factor frequency electrocautery, 68 carcinomatous pleuritis, 323 (EGFR), 44 r cholangiocarcinoma, 72 caudal pancreatectomy, 393 epitrochlear lymph node nonal treatment, 585 CD105, 446 esophageal cancer, 258 an papilloma virus (HPV), 80 cell cycle, 379 468, 541 nans, 682 cell line, 682 esophageal squamous c¢ opharyngeal cancer, 468 central venous ports, 24 noma, 477 sterectomy, 373 713 714 Subject Index iatrogenic disease, 682 lymphoscintigraphy, 286 obesity, 16] ileostomy, 161 lysophosphatidic acid, 30 older age, 100 imaging methods, 650 operative indication, 422 imatinib, 304 malignancy, 80 oral, 593 immunohistochemical staining, 13 malignant sacral tumors, 31 2 oral cancer, 593 immunohistochemistry (IHC), 139, malnutrition, 705 osteofibrous dysplasia, 429 491, 498, 541, 578 mandible, 593 Osteosarcoma, 578 incidence, 279 margin status, 294 osteotomy, 593 incidental gallbladder cancer, 670, mast cells, 36 esteotomy of sacral foramen, 312 690 matrix metalloproteinase (MMP)-2 outcomes, 439 infection, 633 and 9, 80 interval lymph node, 286 maxillary sinus cancer, 362 p27, 241 intra-arterial chemotherapy, 485 melanoma, 279, 355, 564 p53, 379 intraductal, 559 melphalan, 410 p53 alterations, 644 intraductal papillary mucinous mesorectal resection, 523 pancreatectomy, 485 carcinoma, 51 |] metalloproteinases, 151 pancreatic cancer, 485 in-transit recurrence, 564 metallothionein, 241 pancreaticoduodenectomy, 51 | intraoperative cholangiography, metastatic colorectal cancer, 387 pancreaticogastrostomy, 51 ] invasive ductal carcinoma, 485 metastatic disease, 699 pancreaticojejunostomy, 511 inverted papilloma, 80 metastasis, 498, 534 parity, 610 involvement, 20 metastasis risk, 446 pathology, 439 isolated lung perfusion, 410 micrometastases, 541 PCNA, 578 isolated tumor cells, 13 microsatellite instability, 644 pelvic exenteration, 92 minimal residual disease, 541 penile cancer, 181 jaw reconstruction, 593 minimally invasive surgery, 120 pesticides, 640 MMP.-?7, 49] pharyngolaryngo-esophagectomy, Klatskin tumor, 199 MMPs, 330 468 K-ras mutations, 644 molecular markers, 241 pigs, 410 molecular pathogenesis of gallblad- pleural lavage cytology, 3 23 laparoscopic antrectomy, 368 der cancer, 644 popiteal lymph node, 286 laparoscopic cholecystectomy, 690 morbidity, 109 portal lymphadenectomy, 690 laparoscopic hepatectomy, 68 mRNA, 62 positron emission tomography, 650 laparoscopic surgery, 318 multidisciplinary management, 92 possible causes, 87 laparoscopy/adverse effects, 682 multivariate analysis, 24 postoperative chemotherapy, 485 laparotomy, 420 multivariate survival analyses, 294 postoperative liver failure, 72 laparotomy/adverse effects, 682 musculoskeletal tumor surgery, 212 postoperative lymphedema, 87 laryngeal carcinoma, 464 mutation, 44 postoperative radiotherapy, 362 less-invasive surgery, 49] myxofibrosarcoma, 294 predictor for response, 145 letrozole, 585 preneoplastic, 615 liver, 338 neck, 564 preoperative chemoradiation, 145, liver metastasis, |, 268 neck dissection, 56, 464 529 liver resection, 186, 273, 690 neck nodes, 56 prognosis, 13, 422, 446, 468 liver surgery, 268 neoadjuvant chemotherapy, 401 prognostic factors, 1, 133, 194 liver tumor, 8 neoplasm, 593 protease activated receptor-2 local recurrence, 350 neoplasm staging, 165, 279 (PAR-2), 139 locally advanced rectal cancer, 92 nickel, 640 pseudomyxoma, 20 locally recurrent rectal cancer, 92 nodal involvement, 221 psychological stress, 571 long bones, 429 nodal metastasis, 133 PTEN, 233 LPA2, 30 node, 129 lung cancer, 323 noninfiltrating, 559 qualitative assessment, 92 lymph node, 534 non-small cell lung cancer, 62 quality of life, 571 lymph node micrometastasis, 477 non-squamous cell malignancies, lymphadenectomy, 181, 373, 393 362 radiation 5, 640 lymphatic metastasis, 464 nutritional status, 705 radical cholecystectomy, 670 Subject Index 715 radical cystectomy, 228 sentinel lymph node biop 1ick-walled gallbladder, 690 radical excision, 312 sentinel node, 100, 355 horacotomy, 268 radiofrequency, 8 sentinel node biopsy, 18 ireadwire saw, 312 radiofrequency ablation, 68, 120, serum CEA, 145 hyroid cancer, 194 387 signet ring cell carcinoma Vid, 429 radiotherapy, 56, 456 silent, 629 TIMPs, 151 radon, 640 splenectomy, 393 tongue cancer, 330 real-time RT-PCR, 477 split therapy, 56 PP-PCR, 504 receiver operating characteristic squamous cell cancer (SC‘ ranshiatal esophagectomy, curve (ROC), 665 squamous cell carcinoma 541 rectal adenocarcinoma, 145 stage IV rectal cancer, 52 rans-tumoral approach, 8 rectal cancer, 173, 350, 529 staging, 181 eatment results, 362 rectosigmoid pouches, 228 staging system, 221 ypsin, 139 recurrence, 129, 373, 511 stomach, 49] mor control, 109 renal transplantation, 273 stones, 624 imo! depth, 330 re-operation, 690 supportive care, 92 tumor length, 258 repeat hepatectomy, | surgery, 173, 199, 304, mor localization, 350 resection, 338 439, 456, 571 umor marker(s), 151, 665 response, 304 surgical exposure, 420 imors 1n elderly, 194 retroperitoneal sarcoma, 456 surgical implantation, 24 imnbull ileostomy, 161 risk factor(s), 173, 318, 624 survival, 1, 133, 221, 258 RT-PCR, 504 498 iderstaging, 439 survival rate, 464 pper urinary tract cancer, 318 S100A4, 498 surviving, 578 rinary diversion, 206, 228 salvage surgery, 422 susceptibility, 44 nary tract, 20 scoring system, 534 symptomatic, 629 Seldinger technique, 24 ariant, 504 selective neck dissection, 464 tamoxifen, 585 VEGF, 330 sentinel, 129, 564 telomeric repeat bindins sentinel lymph node, 109, 286, 550 62 ‘r, 640 Journal of Surgical Oncology Online Submission and Peer Review To facilitate seamless international scholarly communication, the Journal of Surgical Oncology is pleased to offer web-based submission and peer review. To submit your manuscript online, please: 1. Prepare your manuscript and illustrations in the appropriate format, according to the instructions given at http://jso-wiley.manuscriptcentral.com/under the “Instructions and Forms” button. Please also be sure that your manuscript conforms to the scientific and style instructions of the journal. 2. At the site, check to see if you already have a account with the journal by clicking on the “Check for Existing Account” button. If you do not have an account, you can create one for yourself at the submission site by clicking on the *““Create an Account” button. Subsequently, to monitor the progress of your manuscript throughout the review process, just login periodically and check your Author Center. 3. Please be sure to study the Instructions and Forms given at the site carefully, and then let the system guide you through the submission process. Online help is available to you at all times during the process. You are also able to exit/re-enter the process at any stage before finally “‘submitting’’ your work. Manuscripts must be submitted electronically; authors are invited to visit the online submission site. All submissions are kept strictly confidential. If you have any questions, do not hesitate to contact us at [email protected]. Journal of Surgical O Table of Conte: Volume 93, Number 1 Repeat Hepatectomy for Recurrent Colorectal Liver Metastases Patrick Pessaux, Emilie Lermite, Olivier Brehant, Jean-lacques | The aim ot this study was to determine the value of repeat tactors that can predict survival The Trans-Metastasis Hepatectomy (Through Metastases Previously Ablat Results of a 13-Case Study of Colorectal Cancer Dominique Elias, Dimitri Manganas, Emmanuel Benizr ind Thierry de Baers This article presents the result Isolated Tumor Cells in Lymph Nodes Are Not a Prognostic Marker for Pat and Stage Il Colorectal Cancer MiRno L ee, Cl Won Hong, Sane h n Yoon, Seok-B I ind Jae-Gahb Park COMMENTARY Mike S.L. Lier Omeo E. Niewe Pseudomyxoma Peritonei and the Urinary Tract: Involvement and Treaty ations R.M. Smeenk, A. Bex |. Verwaal, S. Horenbla md F.A.N Urinary tract involvement and urologic complications peritonei a are. They may be a result of seeding of PMP Surgical Technique for Totally Implantable Access Ports (TIAP) Needs I iriate Analysis of 400 Patients Christoph M. Seiler, Boris E.F rohlich, Ulrich J. Dorsam, P nd Hanns-Pet morbidity noditied approact Differential Expression of Lysophosphatidic Acid Receptor-2 in Intestin tric Cancer Hirohar y Shida lak nd Hirok Expression of Chymase-Positive Cells in Gastric Cancer and Its Correlat O)} COMMENTARY Harvey G. Moor The Epidermal Growth Factor Receptor Gene Sequence is Highly Conser\ Cancers Suck lest i ned the Upregulation of Thymidine Phosphorylase in Rectal Cancer Tissues by Mi Yutaka Ogata, Keiko Matono, Teruo Sasat i, Nob Tomoahk Mizone Natsum Yan enous administration of MMC m vould suggest ombination (K)W ILEY-LISS A WILEY-LISS PUBLICATION Split Therapy: Planned Neck Dissection Followed by Definitive Radiotherapy for a T1, T2 Pharyngolaryngeal Primary Cancer With Operable N2, N3 Nodal Metastases—A Prospective Study A.K. D’cruz, G.H. Pantvaidya, J.P. Agarwal, D.A. Chaukar, K.A. Pathak, M.S. Deshpande, P.S. Pai, P. Chaturvedi and K.A. Dinshaw \ prospective study to evaluate the feasibility of planned neck dissection prior to definitive radiotherapy in patients with a small (T1, T2) pharyngolaryngeal primary and large metastatic adenopathy (N2, N3 Expression of Telomeric Repeat Binding Factor 1 in Non-Small Cell Lung Cancer Jian Hu, Li Sun, Chong Zhang, and Xielai Zhou Our study was designedt o evaluate expressions of TRF 1 mRNA in NSCLC. Moreover, we investigated the ditterence of TRF1 expression among the grades of tumor differentiation, clinical stages, and path logical subtypes and | ymph node metastasis in lung cancer tissues. How | Do It: A New Laparoscopic-Assisted Hepatectomy (LAH) Utilizing Radiofrequency Ablation and High-Frequency Electrocautery Mitsuo Miyazawa, Takahiro Torii, Yasuko Toshimitsu, Katsuya Okada, Nobuji Ogawa, Nozomi Shinozuka and Isamu Koyama How | Do It: Extended Right Hepatectomy for Hilar Cholangiocarcinoma With Resection of the Left Hepatic Duct Prior to Hepatic Resection Mitsuo Miyazawa, Yasuko Toshimitsu, Takahiro Torii, Katsuya Okada, and lsamu Koyama Case Report: Major Extremity Amputation for Nodal Metastasis From Squamous Cell Carcinoma Elizabeth A. Johnston, Jukes P. Namm, and Mark E. Reeves COMMENTARY Constantine P. Karakousis Review Article: Increased Expression of Matrix Metalloproteinase-2 and 9 and Human Papilloma Virus Infection Are Associated With Malignant Transformation of Sinonasal Inverted Papilloma Hideaki Katori, Akinori Nozawa, and Mamoru Tsukuda We investigatthee d spectrumo f MMP-an2d 9 expressiino nEP , IP with dysplasia, and IP with carcinoma, and invasive SCC using quantitative inmmunohistochemical analysis. We also compared the presence of MMP-2 and 9 with HPV status. Volume 93, Number 2, February 1, 2006 Surgical Procedures and Lymphedema of the Upper and Lower Extremity Constantine P. Karakousis The potential development of lymphedema atter a node dissection, more frequent in the lower extremity, can be attected by the surgical technique. Qualitative Assessment of Patient Experiences Related to Extended Pelvic Resection for Rectal Cancer F.C. Wright, D. Crooks, M. Fitch, E. Hollenberg, B.A. Maier, L.D. Last, E.G reco, D. Miller, C.H.L. Law, S. Sharir N.E. Fleshner, and A.J. Smith Patients who undergo multimodal therapy tor locally advanced and locally recurrent rectal cancer have a limited understanding of their morbidity and expected survival; however, despite the challenges of their treatment course they are thanktul to be able to complete it. Population-Based Analysis of Lymphatic Mapping and Sentinel Lymphadenectomy Utilization for Intermediate Thickness Melanoma Karyn B. Stitzenberg, Nancy E. Thomas, Laura M. Beskow, and David W. Ollila A population-based analysis of sentinel node utilization tor melanoma reveals that less than halt of patients with intermediate thickness melanoma undergo sentinel lymphadenectomy. Older patients and peients with head or neck primary tumors are significantly less likely to receive surgical nodal staging COMMENTARY Marianne Berwick Long-Term Morbidity of Patients With Early Breast Cancer After Sentinel Lymph Node Biopsy Compared to Axillary Lymph Node Dissection Tobias Schulze, Jorg Mucke, Jorn Markwardt, Peter M. Schlag, and Andreas Bembenek In order to evaluate long-term morbidity after SLNB in patients with early breast cancer, arm/shoulder function and subjective complaints of patients after SLNB and ALND were assessed and compared. Isolated SLNB in node-negative pT1 breast cancer patients proved to be a highly etticient tool to reduce postoperative long-term morbidity without compromising the local control of the disease Radiofrequency Ablation of Small Breast Cancer Followed by Surgical Resection Masakuni Noguchi, Mitsuharu Earashi, Hisatake Fujii, Koichi Yokoyama, Ken-ichi Harada, and Koichi Tsuneyama This study was performed to determine the feasibility and satety of treating small breast cancer with radiotrequency (RF) ablation.